<SEC-DOCUMENT>0001193125-20-231317.txt : 20200826
<SEC-HEADER>0001193125-20-231317.hdr.sgml : 20200826
<ACCEPTANCE-DATETIME>20200826163455
ACCESSION NUMBER:		0001193125-20-231317
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20200826
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200826
DATE AS OF CHANGE:		20200826

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		201137647

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d946237d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20200826" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-08-26_to_2020-08-26">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-08-26_to_2020-08-26">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-08-26_to_2020-08-26">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cvs-20200826.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-08-26_to_2020-08-26"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-08-26</xbrli:startDate> <xbrli:endDate>2020-08-26</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-08-26_to_2020-08-26">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt:datemonthdayyearen">August&#160;26, 2020</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g946237g39t70.jpg" alt="LOGO" /></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-08-26_to_2020-08-26">001-01011</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-08-26_to_2020-08-26">05-0494040</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-08-26_to_2020-08-26">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-08-26_to_2020-08-26">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:stateprovnameen">Rhode Island</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-08-26_to_2020-08-26">02895</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-08-26_to_2020-08-26">(401)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-08-26_to_2020-08-26">765-1500</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report: N/A</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-08-26_to_2020-08-26">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-08-26_to_2020-08-26">CVS</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-08-26_to_2020-08-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;8 - Other Events </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&#160;26, 2020, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221;), issued press releases announcing the (A)&#160;early results and (B)&#160;pricing, respectively, of its cash tender offers (each, a &#8220;Tender Offer&#8221; and collectively, the &#8220;Tender Offers&#8221;) for (i)&#160;up to $3,000,000,000 aggregate principal amount (the &#8220;2023 Notes Maximum Amount&#8221;) of its 4.000% Senior Notes due 2023 and 3.700% Senior Notes due 2023 and the 2.800% Senior Notes due 2023 issued by its wholly-owned subsidiary, Aetna Inc. (collectively, the &#8220;2023 Notes&#8221;) and (ii)&#160;up to $3,000,000,000 aggregate principal amount (the &#8220;2025 Notes Maximum Amount&#8221; ) of its 4.100% Senior Notes due 2025 and 3.875% Senior Notes due 2025 (collectively, the &#8220;2025 Notes&#8221;, and, together with the 2023 Notes, the &#8220;Notes&#8221;) validly tendered and accepted for purchase in connection with the Company&#8217;s previously announced cash tender offers commenced on August&#160;12, 2020. The sum of the 2023 Notes Maximum Amount and the 2025 Notes Maximum Amount is $6,000,000,000 (the &#8220;Aggregate Maximum Amount&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because the Company expects to accept for purchase the Maximum Aggregate Amount of Notes, no additional Notes will be purchased pursuant to the Tender Offers after August&#160;27, 2020, the early settlement date for such Notes validly tendered and accepted for purchase by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of the press releases are attached hereto as Exhibits 99.1 and 99.2, which are incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;9 - Financial Statements and Exhibits </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Exhibits</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> are as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INDEX TO EXHIBITS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d946237dex991.htm">Press Release of CVS Health Corporation dated August&#160;26, 2020 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d946237dex992.htm">Press Release of CVS Health Corporation dated August&#160;26, 2020 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="font-weight:bold">CVS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: August&#160;26, 2020</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Colleen M. McIntosh</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Colleen M. McIntosh</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Senior Vice President, Chief Governance Officer and Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d946237dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g946237g39t70.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Valerie Haertel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Media</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">T.J. Crawford</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Investor Relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">External Affairs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(401) <FONT STYLE="white-space:nowrap">770-4050</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(212) <FONT STYLE="white-space:nowrap">457-0583</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS Health Corporation Announces Early Results of Tender Offers </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WOONSOCKET, RI, August&nbsp;26, 2020 &#150; CVS Health Corporation (&#147;CVS Health&#148;, NYSE: CVS) announced today the early results of the previously
announced cash tender offers (each, a &#147;Tender Offer&#148; and collectively, the &#147;Tender Offers&#148;) for (i)&nbsp;up to $3,000,000,000 aggregate principal amount (the &#147;2023 Notes Maximum Amount&#148;) of its 4.000% Senior Notes due
2023 and 3.700% Senior Notes due 2023 and the 2.800% Senior Notes due 2023 issued by its wholly-owned subsidiary, Aetna Inc. (collectively, the &#147;2023 Notes&#148;) in the priorities set forth in the first table below (the &#147;2023 Notes Tender
Offers&#148;) and (ii)&nbsp;up to $3,000,000,000 aggregate principal amount (the &#147;2025 Notes Maximum Amount&#148; and, together with the 2023 Notes Maximum Amount, the &#147;Maximum Amounts&#148;) of its 4.100% Senior Notes due 2025 and 3.875%
Senior Notes due 2025 (collectively, the &#147;2025 Notes&#148; and, together with the 2023 Notes, the &#147;Notes&#148;) in the priorities set forth in the second table below (the &#147;2025 Notes Tender Offers&#148;). Each group of Tender Offers
that constitutes either the 2023 Notes Tender Offers or the 2025 Notes Tender Offers is referred to as the &#147;Capped Tender Offers&#148;. The sum of the 2023 Notes Maximum Amount and the 2025 Notes Maximum Amount is $6,000,000,000 (the
&#147;Aggregate Maximum Amount&#148;), which represents the aggregate principal amount of the Notes subject to the Tender Offers and excludes any Accrued Interest (as defined below) or Early Tender Payment (as defined below). The Tender Offers are
being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated August&nbsp;12, 2020 (as amended or supplemented from time to time, the &#147;Offer to Purchase&#148;), which sets forth a detailed description of the
Tender Offers. The Tender Offers are open to all registered holders (individually, a &#147;Holder&#148; and collectively, the &#147;Holders&#148;) of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The 2023 Notes Tender Offers </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8pt"><B>Title of Notes</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CUSIP&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Original&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Issuer&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acceptance&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Priority&nbsp;&nbsp;<BR>Level<SUP STYLE="font-size:85%; vertical-align:top">(1)&nbsp;&nbsp;</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Early&nbsp;Tender&nbsp;&nbsp;<BR>Payment<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;&nbsp;
</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Outstanding&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount&nbsp;&nbsp;<BR>Tendered&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><B>Principal&nbsp;&nbsp;<BR>Amount&nbsp;&nbsp;<BR>Expected to be&nbsp;&nbsp;<BR>Accepted
for&nbsp;&nbsp;<BR>Purchase&nbsp;&nbsp;</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.000% Senior Notes due 2023</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650&nbsp;CC2&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">1&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,250,000,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$722,809,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$722,809,000&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.700% Senior Notes due 2023</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650&nbsp;CV0&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">CVS Health&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">2&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$6,000,000,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$4,008,643,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$2,277,191,000<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.800% Senior Notes due 2023</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">00817Y&nbsp;AV0&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">Aetna Inc.&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">3&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,300,000,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$942,532,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$0&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The 2025 Notes Tender Offers </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8pt"><B>Title of Notes</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CUSIP&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Original&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Issuer&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acceptance&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Priority&nbsp;&nbsp;<BR>Level<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Early&nbsp;Tender&nbsp;&nbsp;<BR>Payment<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;&nbsp;
</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal&nbsp;&nbsp;<BR>Amount&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Outstanding</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount&nbsp;&nbsp;<BR>Tendered&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><B>Principal&nbsp;&nbsp;<BR>Amount&nbsp;&nbsp;<BR>Expected to be&nbsp;&nbsp;<BR>Accepted
for&nbsp;&nbsp;<BR>Purchase&nbsp;&nbsp;</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.100% Senior Notes due 2025</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650&nbsp;CW8&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">1&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$5,000,000,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$3,951,753,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$2,999,994,000<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.875% Senior Notes due 2025</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650&nbsp;CL2&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">CVS Health&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">2&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$2,828,067,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,434,282,000&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$0&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the Aggregate Maximum Amount, the Maximum Amounts and proration, the principal amount of each series
of Notes that is purchased in each of the Tender Offers will be determined in accordance with the applicable acceptance priority level (in numerical priority order) specified in this column. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Per $1,000 principal amount of Notes validly tendered at or prior to the Early Tender Date and accepted for
purchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After application of proration. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consideration to be paid in the Tender Offers for each series of Notes validly tendered and expected to
be accepted for purchase as described in the Offer to Purchase (the &#147;Total Consideration&#148;) will be determined at 9:00 a.m., New York City time, on August&nbsp;26, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of 5:00 p.m., New York City time, on August&nbsp;25, 2020 (the &#147;Early Tender Date&#148;), as reported by D.F. King&nbsp;&amp; Co., Inc., the Tender
and Information Agent for the Tender Offers, the principal amounts of the Notes listed in the tables above have been validly tendered and not validly withdrawn.&nbsp;The Withdrawal Deadline of 5:00 p.m., New York City time, on August&nbsp;25, 2020
has passed and, accordingly, Notes validly tendered in the Tender Offers may no longer be withdrawn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health expects to accept for purchase and make
payment for Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date on August&nbsp;27, 2020 (the &#147;Early Settlement Date&#148;), subject to the acceptance priority levels applicable to the relevant series as
described in the Offer to Purchase and, in the case of the 3.700% Senior Notes due 2023 for the 2023 Notes Tender Offers and in the case of the 4.100% Senior Notes due 2025 for the 2025 Notes Tender Offers, to proration as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because the aggregate principal amount of 2023 Notes validly tendered would exceed the 2023 Notes Maximum Amount, CVS Health expects that it will accept
validly tendered 3.700% Senior Notes due 2023 on a prorated basis in accordance with the Offer to Purchase and none of the validly tendered 2.800% Senior Notes due 2023. Because the aggregate principal amount of 2025 Notes validly tendered would
exceed the 2025 Notes Maximum Amount, CVS Health expects that it will accept validly tendered 4.100% Senior Notes due 2025 on a prorated basis in accordance with the Offer to Purchase and none of the 3.875% Senior Notes due 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because CVS Health expects to accept for purchase the Maximum Aggregate Amount of Notes, no additional Notes will be purchased pursuant to the Tender Offers
after the Early Settlement Date. As described in the Offer to Purchase, Notes tendered and not accepted for purchase will be promptly returned to the tendering Holder&#146;s account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of all Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date and accepted for purchase are eligible to receive the
applicable Total Consideration, which includes the applicable Early Tender Payment of $30 per $1,000 principal amount of Notes tendered at or prior to the Early Tender Date (the &#147;Early Tender Payment&#148;). In addition to the applicable Total
Consideration, Holders of Notes accepted for purchase will receive accrued and unpaid interest up to, but not including, the Early Settlement Date (&#147;Accrued Interest&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to terminate the Tender Offers at any time prior to the Expiration
Date. The Tender Offers are not conditioned on any minimum principal amount of Notes being tendered but the Tender Offers are subject to certain conditions as described in the Offer to Purchase. Each Tender Offer is a separate offer. The Capped
Tender Offers are not conditioned on each other. Each Tender Offer may be individually amended, extended or terminated by CVS Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health has
retained Barclays Capital Inc., Goldman Sachs&nbsp;&amp; Co. LLC and J.P. Morgan Securities LLC to act as Dealer Managers for the Tender Offers. D.F. King&nbsp;&amp; Co., Inc. has been retained to act as the Tender and Information Agent for the
Tender Offers. Requests for assistance relating to the procedures for tendering Notes may be directed to the Tender and Information Agent either by email at cvs@dfking.com, or by phone (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> (for
banks and brokers only) or (800) <FONT STYLE="white-space:nowrap">714-3305</FONT> (for all others toll free). Requests for assistance relating to the terms and conditions of the Tender Offers may be directed to Barclays Capital Inc. at (800) <FONT
STYLE="white-space:nowrap">438-3242</FONT> (toll free) or (212) <FONT STYLE="white-space:nowrap">528-7581</FONT> (collect), Goldman Sachs&nbsp;&amp; Co. LLC at (800) <FONT STYLE="white-space:nowrap">828-3182</FONT> (toll free) or (212) <FONT
STYLE="white-space:nowrap">902-6351</FONT> (collect) or J.P. Morgan Securities LLC at (866) <FONT STYLE="white-space:nowrap">834-4666</FONT> (toll free) or (212) <FONT STYLE="white-space:nowrap">834-8553</FONT> (collect). Beneficial owners may also
contact their broker, dealer, commercial bank, trust company or other nominee for assistance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to sell or
purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be
unlawful. The Tender Offers are being made solely pursuant to the Offer to Purchase made available to Holders of the Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Notes, or any of
their respective affiliates, is making </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Notes in response to the Tender Offers. Holders are urged to evaluate carefully
all information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Notes in the Tender Offers, and, if so, the principal amount of Notes to tender. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CVS Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health employees are united around
a common goal of becoming the most consumer-centric health company. We&#146;re evolving based on changing consumer needs and meeting people where they are, whether that&#146;s in the community at one of our nearly 10,000 local touchpoints, in the
home, or in the palm of their hand. Our newest offerings &#151; from HealthHUB<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions
&#151; are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we&#146;re transforming health at www.cvshealth.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Concerning Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By
their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated
by the forward-looking statements due to the risks and uncertainties related to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the geographies impacted and the severity and duration of the pandemic, the pandemic&#146;s impact on the
U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic, as well as the risks and
uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading &#147;Cautionary Statement Concerning Forward-Looking Statements&#148; in our most recently filed
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended June&nbsp;30, 2020 and our recently filed Current Reports on Form <FONT
STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on CVS Health&#146;s forward looking statements. CVS Health&#146;s
forward-looking statements are and will be based upon management&#146;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any
duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d946237dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g946237g39t70.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Valerie Haertel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Media</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">T.J. Crawford</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Investor Relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">External Affairs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(401) <FONT STYLE="white-space:nowrap">770-4050</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(212) <FONT STYLE="white-space:nowrap">457-0583</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS Health Corporation Announces Pricing of Tender Offers </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WOONSOCKET, RI, August&nbsp;26, 2020 &#150; CVS Health Corporation (&#147;CVS Health&#148;, NYSE: CVS) announced today the applicable Reference Yields and
Total Consideration (each as summarized in the tables below) to be paid in connection with the previously announced cash tender offers (each, a &#147;Tender Offer&#148; and collectively, the &#147;Tender Offers&#148;) for (i)&nbsp;up to
$3,000,000,000 aggregate principal amount (the &#147;2023 Notes Maximum Amount&#148;) of its 4.000% Senior Notes due 2023 and 3.700% Senior Notes due 2023 and the 2.800% Senior Notes due 2023 issued by its wholly-owned subsidiary, Aetna Inc.
(collectively, the &#147;2023 Notes&#148;) in the priorities set forth in the Offer to Purchase (as defined below) (the &#147;2023 Notes Tender Offers&#148;) and (ii)&nbsp;up to $3,000,000,000 aggregate principal amount (the &#147;2025 Notes Maximum
Amount&#148; and, together with the 2023 Notes Maximum Amount, the &#147;Maximum Amounts&#148;) of its 4.100% Senior Notes due 2025 and 3.875% Senior Notes due 2025 (collectively, the &#147;2025 Notes&#148; and, together with the 2023 Notes, the
&#147;Notes&#148;) in the priorities set forth in the Offer to Purchase (the &#147;2025 Notes Tender Offers&#148;). Each group of Tender Offers that constitutes either the 2023 Notes Tender Offers or the 2025 Notes Tender Offers is referred to as
the &#147;Capped Tender Offers&#148;. The sum of the 2023 Notes Maximum Amount and the 2025 Notes Maximum Amount is $6,000,000,000 (the &#147;Aggregate Maximum Amount&#148;), which represents the aggregate principal amount of the Notes subject to
the Tender Offers and excludes any Accrued Interest (as defined below) or Early Tender Payment (as defined below). The Tender Offers are being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated August&nbsp;12,
2020 (as amended or supplemented from time to time, the &#147;Offer to Purchase&#148;), which sets forth a detailed description of the Tender Offers. The Tender Offers are open to all registered holders (individually, a &#147;Holder&#148; and
collectively, the &#147;Holders&#148;) of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable Reference Yield for the Notes and the Total Consideration for the Notes are
summarized in the tables below: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The 2023 Notes Tender Offers<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Title of
Notes</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>CUSIP<BR>Number</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Original<BR>Issuer</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acceptance&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Priority&nbsp;&nbsp;<BR>Level&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>UST Reference<BR>Security</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Fixed&nbsp;&nbsp;<BR>Spread&nbsp;&nbsp;<BR>(bps)&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Reference&nbsp;&nbsp;<BR>Yield&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Consideration<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;&nbsp;</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.000%
Senior Notes due 2023</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650&nbsp;CC2&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">1&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">0.125%&nbsp;UST&nbsp;due&nbsp;07/15/2023&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">20&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">0.190%&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,108.36&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.700%
Senior Notes due 2023</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650&nbsp;CV0&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">2&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">0.125%&nbsp;UST&nbsp;due&nbsp;07/15/2023&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">25&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">0.190%&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,079.36&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The 2025 Notes Tender Offers<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Title of
Notes</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>CUSIP<BR>Number</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Original<BR>Issuer</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acceptance&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Priority&nbsp;&nbsp;<BR>Level&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>UST Reference<BR>Security</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Fixed&nbsp;&nbsp;<BR>Spread&nbsp;&nbsp;<BR>(bps)&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Reference&nbsp;&nbsp;<BR>Yield&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total&nbsp;&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Consideration<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;&nbsp;</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.100%
Senior Notes due 2025</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650&nbsp;CW8&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">1&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">0.250%&nbsp;UST&nbsp;due&nbsp;07/31/2025&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">36&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">0.309%&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,148.89&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Because the aggregate principal amount of 2023 Notes validly tendered would exceed the 2023 Notes Maximum
Amount, none of the validly tendered 2.800% Senior Notes due 2023 are expected to be accepted for purchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Per $1,000 principal amount of Notes validly tendered at or prior to the Early Tender Date and accepted for
purchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Because the aggregate principal amount of 2025 Notes validly tendered would exceed the 2025 Notes Maximum
Amount, none of the validly tendered 3.875% Senior Notes due 2025 are expected to be accepted for purchase. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Total Consideration for each $1,000 principal amount of the Notes was determined in the manner described
in the Offer to Purchase by reference to the applicable fixed spread set forth in the tables above plus the yield to maturity or first par call date, as the case may be, of the applicable U.S. Treasury reference securities (the &#147;UST Reference
Security&#148;) set forth in the tables above on the <FONT STYLE="white-space:nowrap">bid-side</FONT> price of such UST Reference Security as of 9:00 a.m., New York City time, on August&nbsp;26, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes validly tendered and not validly withdrawn at or prior to 5:00 p.m., New York City time, on August&nbsp;25, 2020 (the &#147;Early Tender Date&#148;)
will be eligible to receive the applicable Total Consideration, which includes the Early Tender Payment of $30 per $1,000 principal amount of Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS
Health expects to accept for purchase and make payment for Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date on August&nbsp;27, 2020 (the &#147;Early Settlement Date&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of all Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date and accepted for purchase are eligible to receive the
applicable Total Consideration, which includes the applicable Early Tender Payment of $30 per $1,000 principal amount of Notes tendered at or prior to the Early Tender Date (the &#147;Early Tender Payment&#148;). In addition to the applicable Total
Consideration, Holders of Notes accepted for purchase will receive accrued and unpaid interest up to, but not including, the Early Settlement Date (&#147;Accrued Interest&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because the aggregate principal amount of 2023 Notes validly tendered would exceed the 2023 Notes Maximum Amount, CVS Health expects that it will accept
validly tendered 3.700% Senior Notes due 2023 on a prorated basis in accordance with the Offer to Purchase and none of the validly tendered 2.800% Senior Notes due 2023. Because the aggregate principal amount of 2025 Notes validly tendered would
exceed the 2025 Notes Maximum Amount, CVS Health expects that it will accept validly tendered 4.100% Senior Notes due 2025 on a prorated basis in accordance with the Offer to Purchase and none of the 3.875% Senior Notes due 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because CVS Health expects to accept for purchase the Maximum Aggregate Amount of Notes, no additional Notes will be purchased pursuant to the Tender Offers
after the Early Settlement Date. As described in the Offer to Purchase, Notes tendered and not accepted for purchase will be promptly returned to the tendering Holder&#146;s account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to terminate the Tender Offers at any time prior to the Expiration
Date. The Tender Offers are not conditioned on any minimum principal amount of Notes being tendered but the Tender Offers are subject to certain conditions as described in the Offer to Purchase. Each Tender Offer is a separate offer. The Capped
Tender Offers are not conditioned on each other. Each Tender Offer may be individually amended, extended or terminated by CVS Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health has
retained Barclays Capital Inc., Goldman Sachs&nbsp;&amp; Co. LLC and J.P. Morgan Securities LLC to act as Dealer Managers for the Tender Offers. D.F. King&nbsp;&amp; Co., Inc. has been retained to act as the Tender and Information Agent for the
Tender Offers. Requests for assistance relating to the procedures for tendering Notes may be directed to the Tender and Information Agent either by email at cvs@dfking.com, or by phone (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> (for
banks and brokers only) or (800) <FONT STYLE="white-space:nowrap">714-3305</FONT> (for all others toll free). Requests for assistance relating to the terms and conditions of the Tender Offers may be directed to Barclays Capital Inc. at (800) <FONT
STYLE="white-space:nowrap">438-3242</FONT> (toll free) or (212) <FONT STYLE="white-space:nowrap">528-7581</FONT> (collect), Goldman Sachs&nbsp;&amp; Co. LLC at (800) <FONT STYLE="white-space:nowrap">828-3182</FONT> (toll free) or (212) <FONT
STYLE="white-space:nowrap">902-6351</FONT> (collect) or J.P. Morgan Securities LLC at (866) <FONT STYLE="white-space:nowrap">834-4666</FONT> (toll free) or (212) <FONT STYLE="white-space:nowrap">834-8553</FONT> (collect). Beneficial owners may also
contact their broker, dealer, commercial bank, trust company or other nominee for assistance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to sell or
purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be
unlawful. The Tender Offers are being made solely pursuant to the Offer to Purchase made available to Holders of the Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Notes, or any of
their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Notes in response to the Tender Offers. Holders are urged to evaluate carefully all
information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Notes in the Tender Offers, and, if so, the principal amount of Notes to tender. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CVS Health </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health employees are united around a common goal of becoming the most consumer-centric health company. We&#146;re evolving based on changing consumer needs
and meeting people where they are, whether that&#146;s in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings &#151; from
HealthHUB<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions &#151; are designed to create a higher-quality, simpler and more
affordable experience. Learn more about how we&#146;re transforming health at www.cvshealth.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Concerning Forward-Looking
Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS
Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially
from those contemplated by the forward-looking statements due to the risks and uncertainties related to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the geographies impacted and the severity and duration of the pandemic, the
pandemic&#146;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic,
as well as the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading &#147;Cautionary Statement Concerning Forward-Looking Statements&#148; in
our most recently filed Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended June&nbsp;30, 2020 and our recently filed Current
Reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on CVS Health&#146;s forward looking
statements. CVS Health&#146;s forward-looking statements are and will be based upon management&#146;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements.
CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cvs-20200826.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/26/2020 11:32:50 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:cvs="http://www.cvshealth.com/20200826"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20200826"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200826_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20200826_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cvs-20200826_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/26/2020 11:32:50 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cvs-20200826_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 8/26/2020 11:32:50 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20200826.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g946237g39t70.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g946237g39t70.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M/_),/$/_ %Z-_2@!OPK_ .27^'O^O4?S- '(_$?CXR_#[_KJW_H0H ]>H *
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6W#/XB@!_V+Q]_P!%$G_\%\?^- '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d946237d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20200826.xsd" xlink:type="simple"/>
    <context id="duration_2020-08-26_to_2020-08-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-26</startDate>
            <endDate>2020-08-26</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-08-26_to_2020-08-26"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-08-26_to_2020-08-26">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-08-26_to_2020-08-26"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-08-26_to_2020-08-26">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-08-26_to_2020-08-26">2020-08-26</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-08-26_to_2020-08-26">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-08-26_to_2020-08-26">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-08-26_to_2020-08-26">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-08-26_to_2020-08-26">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-08-26_to_2020-08-26">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-08-26_to_2020-08-26">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-08-26_to_2020-08-26">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-08-26_to_2020-08-26">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-08-26_to_2020-08-26">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-08-26_to_2020-08-26">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-08-26_to_2020-08-26">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-08-26_to_2020-08-26">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-08-26_to_2020-08-26">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-08-26_to_2020-08-26">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-08-26_to_2020-08-26">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-08-26_to_2020-08-26">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-08-26_to_2020-08-26">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140206022610680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 26,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !;A!I13LQGT2@$   V$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)6846_J-A3'G^\^A87VL$EM8Z= Z15%HK1=T>WM187=:IOV8!(#5A,[LYU"
MO_V. R1L"R>,!X@3GW]^]K'_MNFOM7FS*R$<V:2)LC>ME7/9YR"PT4JDW%[H
M3"AXLM FY0Z*9AG8S @>%T%I$H24=H.42]4:](M[$S/HZ]PE4HF)(39/4VX^
M;D6BUS<MUMK?>)'+E?,W@D$_XTLQ%>[7;&*@%)0JL4R%LE(K8L3BIC5DGV_#
MM@\H:GR78FT/KHEORESK-U\8QS<MZHE$(B+G)3C\O(N12!*O!!Q_[41;Y3M]
MX.'U7OVA:#PT9LZM&.GD5<9N==/JM4@L%CQ/W(M>/XI=@SI>+]*)+;[)>ENW
M35LDRJW3Z2X8"%*IMK]\L^N(4P+"74!8<&]?5%#><<<'?:/7Q/C:H.8OBJ86
MT0 GE<_*U!EX*B'.#>YTE$,G.\)53.Z5D^Z#C-4VV]!K_<#!2WS5(-H)WFX%
MPR."PWQY0<+N&0EI2/\9'@!;"1B6@&&A=WE$;Z3?A2%_#.?6&4CAGXCD92EY
M64BVCTCNFODBEM*+0N.?>2KJFHKKC+Y/R>/]\&GV2$;:9 A9NR1KHXI#2$5<
MI.,AX<LZ(CQ^P1,K$(Y.R=$YI8=&0&)X @,B%AOR17S4$>%*U'^Z[1Z]1+"Z
M)587%2L'Z^PCJ\T7'MX[_X) 7)405Z=!3(21VD^:F,#4J^7!E?93Y8=/GQHF
M2Z]DZYV2M[&*8#QJ4TQA,G5 !R,TAV1"3G5<BXH+W]TC=-<EW?4I= \R$>0Y
M3^?"U('@&I2R<\HH8P@/HY7YT5.(9GQ#QC'D5"YDM.VTXWP-DK1S3MO7;=K&
M\LD.[)F=0CB,8R.L/=M?D">H1[ZIVE0V2$(4\=9U9V ]Q" KBV;A_X(<^9(V
M9*;7]2L(+O>JM;(Z>A,.HZO<GIUD]R7==CX WL3H=ZFB^C[$-5_&&%IE]PSW
MZW^C3;1UX+>_R^SH/&U0I&'ONH.Q54L PYV[2.(0=GK'47"!G]J4_8RA5+;/
M<.-^TA'TRF2E%68<#2)7W<XYZU!T6E9K ,.M^]5(YX2"KDG37.U,P]92X4)-
M*S:KK)_A%CW5B8RDDVI)OL( -Y(GM3RX2B-/9?8,=^J)$47W")AAVT4;]C:P
ME?NV6!S)'Z[71!96KA_B%OT?LK&U.9 U 3;(-@)6IA_B#CT546[\]&/AG,RD
M2VJG7X.(;V&Q^H.3GI&,&_+.DUR0'^D%922#AMH5-RCPP1X==^R9X;$?>-./
M=*YKAUV# *Q'&$CE]2'NRV7/W6^B%5=+<71KWR#T_-L4V_*$E<6')UG\?2K,
MTG?1+Z#@5G[\95S5;J@;!(\.L^#@%.A/U%^Y?Z,EB5B $+VX KLVVT/JMN!T
M5AP,Y]K!,;.X7,'!7AA? 9XOM';[@C]KEG\5#/X&4$L#!!0    ( %N$&E&#
MJ:4#U $  #(&   -    >&PO<W1Y;&5S+GAM;-55VXK40!#]E:8_P)Y$=D%)
M BHL""H+.P^^=I)*TM W.Y4QV:^W.YW;N RH#Z(ODSJGJD^=OD[6XR3AJ0-
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 6X0:4660>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( %N$&E'YP4WW[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %N$&E&97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ 6X0:44[,9]$H!   -A   !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %N$&E&#J:4#U $
M #(&   -              "  6P,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  .\2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d946237d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d946237d8k.htm">d946237d8k.htm</File>
    <File>cvs-20200826.xsd</File>
    <File>cvs-20200826_lab.xml</File>
    <File>cvs-20200826_pre.xml</File>
    <File>d946237dex991.htm</File>
    <File>d946237dex992.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g946237g39t70.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d946237d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d946237d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20200826_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20200826_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20200826.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20200826",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d946237d8k.htm",
      "contextRef": "duration_2020-08-26_to_2020-08-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d946237d8k.htm",
      "contextRef": "duration_2020-08-26_to_2020-08-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20200826/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-20-231317-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-231317-xbrl.zip
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M=G,M,C R,# X,C9?;&%B+GAM;,V<;4_C1A#'WY]TWV&:OFFE<Y[0]4H$G&B
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M<E,M301Q)DA2$=T?;-"&Y09A62_9'5=ZR_P'C&07C_\/A-[S'U!+ P04
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M)E6>X6=,-'3E'">055>F)ZY$_B%4=<$>9=]AOO 2\QWC\#C/1J!.8[JMJSK
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M]OM6S7]0,9,M7&6.!GR CRT'DX2:Q'9A9B:[7Z9$MP!MFE:O)&S87[_O2=U
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MH['4MQ7JQFZC:NPTEORVPN[N+OS=6MU6^&EMMRKE\TO8[K/ENN2_NF3X^JW
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M.U!]:81_HYE/=[/($\&6'H$+]+0D;&FAJ)CRC%(4M_F8O (5#B&F!:T80FK
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MGX$3XR9']*4I@>7874Q+![<#=WW-5-U*48*DKV7= +.!^L< *1N-A$]OXH8
MD^E' 2KZD8>6#* C80;MCTE%D1/?I]?073RW(J^ LAC4;<B%(=H:Z:Y5L&&4
M$<-=$ C<@JF3#E(:G(YP3=@6<6:]X!V6>85:;^5>4EHN4/$;@.4IXVRD^_F<
MNVIB(_.V,77HL!$2D#^)(Z@IDU2^PS\@8H$E35H0GNEN1Q'\$P.<GS>9CG('
M/=#HD0/N3S^RY_DMJ5Y0Z$Z!8<Z'6;-A*8WF-Z"6X]12RGW-8*]"UZEM5<3)
M63QCL270Y"=I%&*&WM,%%7-15/O8S QE7 \C;[G?E[;D-$[BKD!#PO1I/3OP
MYAPPS$@M2XMM,U<ZX,G.*?*_X5&+(5^=^=Q?DV!>'P,+TGB.E60*09C&0]6V
MS_5)K\1R'0QI0\6=+U&P^CYZX*IQ6>+O<*4[<'H\<)CV'I-QND8Z))2@KT1A
M'J.<K(F[,_('RIX+B,LC=-!-> S;F=IRPF(RM5WFIS10/49VK/C!+L!8;+9,
ML1\UT./?(6:]D4&<EL5D>&JX)4P9D ,2$XCB*8([P:O@2$3EC?N@6N9?I]"A
M>#S?XCBS^1C\QU^/ZKD0:*6<_H(:(JEUMQ\[O!UYMCM!;49<=B2Z;=P'DD#
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M:_52L4">$Q'D8\3&1B*""'R>0-3A^T!Y8Q:"0Z9IX?_L"EN89DXV@%=@$./
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M\?\03@L_Y!#?S%;K5M:2'L!TY*!RKE.ZZ0PBH#(G N+#95MA=[ W/Z6ZK%Q
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MDU<LK$4K)8T>=N[+FT.G5RS;Q"QNRE8"48=)>[9$1-3&,M6')XEU8]T;8;]
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M)/L^&% [\<"3[8 U!.?J20ZF<-K]*'O*0[V:VMBMGTJ)_KB6EF$@:/WW%8'
M9TWB[]=FU;4:R.+)S%B5+[8*XR,M PP#H&D54@* 'F\*IP WV-!D[N[S%X$R
M\5]02P$"% ,4    " !;A!I1J33+;V0#   G#   $               @ $
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M+FAT;5!+ 0(4 Q0    ( %N$&E%NRL-#N!0  'M\   1              "
M 6$U  !D.30V,C,W9&5X.3DR+FAT;5!+ 0(4 Q0    ( %N$&E$AC6P ! \
M (X/   1              "  4A*  !G.30V,C,W9S,Y=#<P+FIP9U!+!08
1    !P ' +L!  ![60     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
